Allyx Therapeutics

$4.5M revenue • 25 employees • 555 Long Wharf Drive, New Haven, CT, 06511, United States

Last Updated Feb 4, 2025

Company Overview

Company Name

Allyx Therapeutics

Address

555 Long Wharf Drive, New Haven, CT, 06511, United States

Approx. Annual Revenue

$4.5M

Employees

25

Established

2019

About Allyx Therapeutics

Allyx Therapeutics is a biopharmaceutical company based in New Haven, Connecticut, focused on developing an oral drug that demonstrates the reversal of learning and memory deficits caused by Alzheimer's disease. The company has received several grants and has initiated clinical studies to advance its lead compound, ALX-001, for the treatment of Alzheimer's and Parkinson's diseases.

Recent changes

What changed on the Allyx Therapeutics website and Google listing, as detected by Coldlytics on each visit.

  1. Estimated headcount moved from 11-20 to 21-50 employees

Coldlytics tracks changes like these across millions of businesses, so you can reach companies the moment they add a pixel, start hiring, or switch software.

Find companies by what just changed →

More Companies in Connecticut

Browse all companies in Connecticut →

Frequently Asked Questions about Allyx Therapeutics

Categories

Technologies Used

Social Profiles

Key Decision Makers

Patrick Simms Vice President Clinical Operations
LinkedIn